Pompe disease, also known as acid maltase disease and glycogen storage disease II, is a rare genetic disorder that results in progressive weakness in the heart and skeletal muscles. This debilitating condition is caused by mutations in a gene responsible for producing an enzyme called acid alpha-glucosidase (GAA). This enzyme plays a crucial role in […]
Read More
According to the Centers for Disease Control (CDC), nearly 6.7 million adults aged 20 years or older in the United States are affected by heart failure. In 2022, heart failure accounted for 13.9% of all causes of mortality. Heart failure is a serious condition with no known cure, but various treatments such as healthy lifestyle […]
Read More
Today, the American College of Cardiology (ACC) and the American Heart Association (AHA) Joint Committee on Clinical Practice Guidelines have released an updated guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. This guideline supersedes the previous 2014 version and incorporates new evidence to provide clinicians with consolidated guidance. Clinicians are advised […]
Read More
Our Guidelines Rundown Series continues with a new article that explores the topic of cholesterol management for National Cholesterol Education Month 2024. To offer guidance and support for clinical decision-making, several societies have released comprehensive guidelines that cover various aspects of cholesterol, including dyslipidemia, the role of non-statin therapies, nutrition, and more. In this article, we […]
Read More
According to the American Heart Association (AHA), atrial fibrillation (AF) impacts between 2.7 and 6.1 million Americans, frequently resulting in heart-related complications and a fivefold increase in the risk of stroke. To address this significant health concern, the American College of Cardiology (ACC), and AHA, in collaboration with and endorsed by the American College of […]
Read More
In the latest edition of the Guidelines International Series, we delve into the most recent guidelines published by the esteemed European Society of Cardiology (ESC). As a global leader in the field of cardiovascular medicine, the ESC brings together a community of over 100,000 scientists, clinicians, nurses, and allied professionals dedicated to advancing best practices […]
Read MoreIn this edition of our Guidelines Monographs Series, we will be taking a look at AstraZeneca’s medication dapagliflozin, brand name Farxiga. Initially approved in 2014, Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, provided to individuals with diabetes, heart disease, or kidney disease to improve their outcomes. This Guidelines+ Monograph will take a deeper dive […]
Read More
High cholesterol, also known as hyperlipidemia, affects millions of individuals in the United States (US). This condition can lead to serious health issues, such as an increased risk of heart disease and stroke. Globally, approximately one-third of cases of ischaemic heart disease are linked to high cholesterol levels. Elevated total cholesterol is a significant contributor […]
Read More